QGEN

Qiagen N.V.

Healthcare›Medical - Diagnostics & Research|New York Stock Exchange|NL

Price

$41.03

Market Cap

$8.46B

Beta

0.71

P/E

20.4

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+5.65%

EPS Growth (YoY)+418.42%

Revenue CAGR 3Y-0.81%

P/E Ratio20.4

PEG Ratio0.05

FCF Yield+5.35%

Debt / Equity0.44

Interest Coverage15.6x

No credit card required

Already have an account? Sign in to view the full analysis for QGEN.